Tesamorelin
Growth Hormone Secretagogue
A well-documented GHRH analog with one of the clearest visceral-fat angles in the broader peptide discussion.
How It Works
Tesamorelin stimulates endogenous growth-hormone release through GHRH signaling, which is part of why it gets discussed in visceral-fat and body-composition contexts.
Practical Information
injection
Tesamorelin is framed as an injectable visceral-fat-focused compound, with practical questions centered on body-composition tracking, prescription access, and approved-use boundaries.
Approved tesamorelin coverage centers on daily subcutaneous administration, with product-specific handling and reconstitution details.
Related Articles
See all 3 articles →Tesamorelin Side Effects: What Happens First
Tesamorelin side effects are usually local and manageable. The bigger question is whether daily injections, glucose monitoring, and the HIV-lipodystrophy-approved label fit your actual needs.
4 min read
Tesamorelin Dosage: Daily Clarity, Two Formulations
Tesamorelin is a straightforward once-daily injection, but EGRIFTA WR and EGRIFTA SV use different strengths and mixing routines. The key insight: this is labeled for HIV-related abdominal fat, not general weight loss.
4 min read